Better Solutions. Better Service.
Founded in 2007, AustinPx is a fee-for-service CDMO offering preclinical through Phase II formulation and process development and GMP manufacturing of oral dosage forms. We specialize in bioavailability enhancement, speed to clinic and market development strategies, and dose form development.
The name AustinPx represents where we come from and what we do. Px stands for Pharmaceutics. To our core, we are a pharmaceutics company. Our approach is data-driven and agnostic which means our formulation strategy for each drug is based on the unique physiochemistry of that compound. And for poorly soluble compounds, we have one of the most powerful tools available in KinetiSol, a truly next generation technology for rendering active pharmaceutical ingredients amorphous.
Based in Georgetown, TX (30 miles from Austin Airport), AustinPx’s cGMP facility can supply oral formulations and dose forms for preclinical testing, GLP toxicology studies, and Phase I/II clinical studies. We can also provide our KinetiSol Amorphous Dispersion Technology drug product intermediate (DPI) through commercial manufacturing.